Multiplex Immunohistochemistry for Mapping the Tumor Microenvironment

Jessica Kalra1,2,3, Jennifer Baker4

  • 1Department of Experimental Therapeutics, British Columbia Cancer Agency, 675 West 10th Avenue, 5th Floor, Vancouver, BC, V5Z 1L3, Canada. jessica.kalra@gmail.com.

Insights

Multiplex Immunohistochemistry (mIHC) enables simultaneous detection of multiple tissue markers in one section. This technique is crucial for understanding complex biological processes and drug mechanisms.

Area of Science:

  • Biomedical research
  • Molecular pathology
  • Cancer research

Background:

  • Multiplex Immunohistochemistry (mIHC) allows simultaneous detection of multiple targets in a single tissue section.
  • Enables evaluation of signal transduction pathways, marker co-localization, and molecular distribution within tissues.
  • Crucial for characterizing molecular signaling and drug action mechanisms.

Purpose of the Study:

  • To describe the principles of designing and implementing multiplex immunohistochemistry (mIHC) protocols.
  • To create parameter tumor maps for various labeled markers.
  • To facilitate detailed analysis of tissue microenvironments and molecular interactions.

Main Methods:

  • Utilizes multiplex immunohistochemistry (mIHC) for simultaneous multi-target detection.
  • Involves designing and implementing mIHC protocols.
  • Employs automated slide imaging and analysis for medium to high-throughput data acquisition.

Main Results:

  • Demonstrates the capability of mIHC to analyze tumor microenvironments, including vascular architecture and hypoxia.
  • Shows utility in assessing cellular proliferation, cell death, and drug distribution.
  • Enables the creation of parameter tumor maps for multiple markers.

Conclusions:

  • Multiplex Immunohistochemistry (mIHC) is a powerful technique for comprehensive tissue analysis.
  • The described protocol facilitates detailed mapping of molecular markers in various biological contexts.
  • mIHC supports advanced research in cancer biology and drug development.